Hjem › Skleroserende cholangitis › Ohio
Skleroserende cholangitis kliniske forsøg i Ohio
5 studier for Skleroserende cholangitis søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Dayton Gastroenterology- Englewood, Beavercreek
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 19. aug. 2026 · NCT05750498MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
- Cincinnati Childrens Hospital Medical Center, Cincinnati
RekruttererObservationsstudie
Alder 6 til 23 · Alle køn · Opdateret 19. aug. 2026 · NCT03175471MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
- Cincinnati Children's Hospital and Medical Center, Cincinnati
RekruttererObservationsstudie
Alder 6 til 23 · Alle køn · Opdateret 19. aug. 2026 · NCT03178630Primary Sclerosing Cholangitis in Children
- Cincinnati Children's Hospital Medical, Cincinnati
RekruttererObservationsstudie
Alder 2 til 25 · Alle køn · Opdateret 14. jul. 2026 · NCT04181138Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.